ImClone Systems Inc (formerly IMCL)

[rjurko]

Neblo, I noticed a post by you the other day--hope you are well!

I wonder whether you would render your opinion, if any, on my speculation that the squamous patients in the NCSLC trials are likely to show a significant benefit from Erbitux. This would seem to follow from the significant benefits shown repeatedly in squamous cell carcinoma of the H & N, a related epithelial cancer.

Thank you. Your contributions are always remembered and appreciated.

Best regards,
rjurko (Bob)